BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26649731)

  • 1. Syndromic versus non-syndromic sporadic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior.
    Rosentraeger MJ; Garbrecht N; Anlauf M; Raffel A; Knoefel WT; Wiedenmann B; Klöppel G
    Virchows Arch; 2016 Mar; 468(3):277-87. PubMed ID: 26649731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
    Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
    World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
    Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
    Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome.
    Pipeleers-Marichal M; Somers G; Willems G; Foulis A; Imrie C; Bishop AE; Polak JM; Häcki WH; Stamm B; Heitz PU
    N Engl J Med; 1990 Mar; 322(11):723-7. PubMed ID: 1968616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The analysis of immunophenotype of gastrin-producing tumors of the pancreas and gastrointestinal tract.
    Gurevich L; Kazantseva I; Isakov VA; Korsakova N; Egorov A; Kubishkin V; Bulgakov G
    Cancer; 2003 Nov; 98(9):1967-76. PubMed ID: 14584081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I.
    Pipeleers-Marichal M; Donow C; Heitz PU; Klöppel G
    World J Surg; 1993; 17(4):481-8. PubMed ID: 8103250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of gastrinomas by immunohistochemistry and in situ hybridization histochemistry.
    Perkins PL; McLeod MK; Jin L; Fukuuchi A; Cho KJ; Thompson NW; Lloyd RV
    Diagn Mol Pathol; 1992 Sep; 1(3):155-64. PubMed ID: 1285276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
    Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
    Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrinoma--morphological aspects.
    Klöppel G; Anlauf M
    Wien Klin Wochenschr; 2007; 119(19-20):579-84. PubMed ID: 17985091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.
    Alexander HR; Fraker DL; Norton JA; Bartlett DL; Tio L; Benjamin SB; Doppman JL; Goebel SU; Serrano J; Gibril F; Jensen RT
    Ann Surg; 1998 Aug; 228(2):228-38. PubMed ID: 9712569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonic hedgehog and pancreatic-duodenal homeobox 1 expression distinguish between duodenal and pancreatic gastrinomas.
    Fendrich V; Ramerth R; Waldmann J; Maschuw K; Langer P; Bartsch DK; Slater EP; Ramaswamy A; Rothmund M
    Endocr Relat Cancer; 2009 Jun; 16(2):613-22. PubMed ID: 19240184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy.
    Donow C; Pipeleers-Marichal M; Schröder S; Stamm B; Heitz PU; Klöppel G
    Cancer; 1991 Sep; 68(6):1329-34. PubMed ID: 1678681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A personal experience with pancreatic and duodenal neuroendocrine tumors.
    Jordan PH
    J Am Coll Surg; 1999 Nov; 189(5):470-82. PubMed ID: 10549736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2.
    Hermann G; Konukiewitz B; Schmitt A; Perren A; Klöppel G
    Virchows Arch; 2011 Aug; 459(2):147-54. PubMed ID: 21739268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1.
    MacFarlane MP; Fraker DL; Alexander HR; Norton JA; Lubensky I; Jensen RT
    Surgery; 1995 Dec; 118(6):973-9; discussion 979-80. PubMed ID: 7491542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors: a prospective study.
    Norton JA; Alexander HR; Fraker DL; Venzon DJ; Gibril F; Jensen RT
    Ann Surg; 2003 May; 237(5):650-7; discussion 657-9. PubMed ID: 12724631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Location, incidence, and malignant potential of duodenal gastrinomas.
    Thom AK; Norton JA; Axiotis CA; Jensen RT
    Surgery; 1991 Dec; 110(6):1086-91; discussion 1091-3. PubMed ID: 1745977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery and prognosis of duodenal gastrinoma as a duodenal neuroendocrine tumor.
    Norton JA
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):699-704. PubMed ID: 16253894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison study of gastrinomas between gastric and non-gastric origins.
    Huang SF; Kuo IM; Lee CW; Pan KT; Chen TC; Lin CJ; Hwang TL; Yu MC
    World J Surg Oncol; 2015 Jun; 13():202. PubMed ID: 26077245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome?
    Norton JA; Alexander HR; Fraker DL; Venzon DJ; Gibril F; Jensen RT
    Ann Surg; 2004 May; 239(5):617-25; discussion 626. PubMed ID: 15082965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.